What is the share price of Poly Medicure Ltd (POLYMED) today?
The share price of POLYMED as on 27th February 2026 is ₹1256.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Poly Medicure Ltd (POLYMED) share?
The past returns of Poly Medicure Ltd (POLYMED) share are- Past 1 week: -1.51%
- Past 1 month: -19.99%
- Past 3 months: -36.15%
- Past 6 months: -40.21%
- Past 1 year: -39.88%
- Past 3 years: 32.73%
- Past 5 years: 75.08%
What are the peers or stocks similar to Poly Medicure Ltd (POLYMED)?
The peers or stocks similar to Poly Medicure Ltd (POLYMED) include:What is the dividend yield % of Poly Medicure Ltd (POLYMED) share?
The current dividend yield of Poly Medicure Ltd (POLYMED) is 0.28.What is the market cap of Poly Medicure Ltd (POLYMED) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Poly Medicure Ltd (POLYMED) is ₹12731.77 Cr as of 27th February 2026.What is the 52 week high and low of Poly Medicure Ltd (POLYMED) share?
The 52-week high of Poly Medicure Ltd (POLYMED) is ₹2937.60 and the 52-week low is ₹1229.What is the PE and PB ratio of Poly Medicure Ltd (POLYMED) stock?
The P/E (price-to-earnings) ratio of Poly Medicure Ltd (POLYMED) is 37.61. The P/B (price-to-book) ratio is 4.60.Which sector does Poly Medicure Ltd (POLYMED) belong to?
Poly Medicure Ltd (POLYMED) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Poly Medicure Ltd (POLYMED) shares?
You can directly buy Poly Medicure Ltd (POLYMED) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Poly Medicure Ltd
POLYMED Share Price
NSE₹1,256.100.21% (-2.60)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
POLYMED Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
POLYMED Performance & Key Metrics
POLYMED Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 36.62 | 4.60 | 0.28% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.86 | 5.82 | 0.58% |
80%
Analysts have suggested that investors can buy this stock
from 5 analysts
Price Upside
Earnings Growth
Rev. Growth
POLYMED Company Profile
Poly Medicure Limited is engaged in the manufacturing and sale of medical devices.
PE Ratio
47.42
47.42
1Y Return
25.08%
25.08%
Buy Reco %
77.78
77.78
FISCHER
PE Ratio
1,665.25
1,665.25
1Y Return
50.69%
50.69%
Buy Reco %
0.00
0.00
ONEGLOBAL
PE Ratio
69.80
69.80
1Y Return
117.16%
117.16%
Buy Reco %
0.00
0.00
LAXMIDENTL
PE Ratio
33.30
33.30
1Y Return
41.45%
41.45%
Buy Reco %
100.00
100.00
TARSONS
PE Ratio
34.10
34.10
1Y Return
37.60%
37.60%
Buy Reco %
100.00
100.00
POLYMED Sentiment Analysis
POLYMED Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
POLYMED Stock Summary · February 2026
In Q3 FY26, the company demonstrated robust financial performance with a consolidated revenue of INR 494 crores, marking a 16.4% year-on-year growth, despite facing extraordinary expenses from labor code implementation and acquisitions. The integration of recent acquisitions is progressing well, particularly in Europe, enhancing market reach and technological capabilities, although competitive pressures from lower-cost Chinese suppliers pose challenges. The company is strategically shifting focus from government contracts to the growing private sector, anticipating a 25% growth in domestic markets and a 12-15% increase internationally. While employee costs have risen due to new hires for high-end product sales, management remains optimistic about maintaining EBITDA margins and achieving a consistent growth rate of 20% in the coming years.
POLYMED Stock Growth Drivers
POLYMED Stock Growth Drivers
7Strategic Transition to High-Growth Segments
The company has successfully transitioned from low technology products to high-complexity, high-growth segments, particularly in
Strong Financial Performance
For the quarter ended December '25, the company reported consolidated revenue of INR 494 crores,
POLYMED Stock Challenges
POLYMED Stock Challenges
6Extraordinary Expenses Impacting Profitability
Poly Medicure Limited has faced extraordinary expenses totaling INR 6.8 crores related to the implementation
Reduced Sales Guidance for Dialysis Machines
The company has revised its sales guidance for dialysis machines downward, reducing the expected sales
POLYMED Forecast
POLYMED Forecasts
Price
Revenue
Earnings
POLYMED Share Price Forecast
POLYMED Share Price Forecast
2026
Current
₹1,256.10
Baseline
Forecast for Feb 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹1,256.10
Baseline
Forecast for Feb 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
POLYMED Company Revenue Forecast
POLYMED Company Revenue Forecast
2025
Current
₹1.76
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.76
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
POLYMED Stock EPS (Earnings Per Share) Forecast
POLYMED Stock EPS (Earnings Per Share) Forecast
2025
Current
₹34.32
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹34.32
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
POLYMED
POLYMED
Income
Balance Sheet
Cash Flow
Quarterly Normal View
POLYMED Income Statement
POLYMED Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 352.22 | 356.88 | 393.28 | 402.13 | 446.86 | 447.73 | 467.41 | 446.65 | 478.79 | 521.60 | ||||||||||
Operating & Other expenses | 253.07 | 249.38 | 281.61 | 280.86 | 304.83 | 309.81 | 321.37 | 297.50 | 329.20 | 389.28 | ||||||||||
EBITDA | 99.15 | 107.50 | 111.67 | 121.27 | 142.03 | 137.92 | 146.04 | 149.15 | 149.59 | 132.32 | ||||||||||
| Depreciation/Amortization | 15.99 | 16.21 | 16.08 | 19.65 | 20.71 | 21.37 | 21.03 | 23.26 | 24.93 | 28.76 | ||||||||||
| PBIT | 83.16 | 91.29 | 95.59 | 101.62 | 121.32 | 116.55 | 125.01 | 125.89 | 124.66 | 103.56 | ||||||||||
| Interest & Other Items | 2.22 | 3.47 | 3.12 | 3.16 | 3.34 | 3.33 | 2.17 | 2.95 | 2.97 | 5.96 | ||||||||||
| PBT | 80.94 | 87.82 | 92.47 | 98.46 | 117.98 | 113.22 | 122.84 | 122.94 | 121.69 | 97.60 | ||||||||||
| Taxes & Other Items | 18.75 | 22.81 | 24.10 | 24.42 | 30.53 | 28.00 | 31.02 | 29.87 | 29.86 | 26.68 | ||||||||||
| Net Income | 62.19 | 65.01 | 68.37 | 74.04 | 87.45 | 85.22 | 91.82 | 93.07 | 91.83 | 70.92 | ||||||||||
| EPS | 6.48 | 6.78 | 7.12 | 7.71 | 9.01 | 8.48 | 8.92 | 9.19 | 9.06 | 7.00 |
POLYMED Company Updates
FY 2026FY 2026
Investor Presentation
Feb 5PDF
Nov 8PDF
Sep 3PDF
POLYMED Stock Peers
POLYMED Past Performance & Peer Comparison
POLYMED Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Poly Medicure Ltd | 37.61 | 4.60 | 0.28% |
| Inventurus Knowledge Solutions Ltd | 47.42 | 12.88 | — |
| Fischer Medical Ventures Ltd | 1,665.25 | 7.34 | 0.13% |
| One Global Service Provider Ltd | 69.80 | 17.97 | — |
POLYMED Stock Price Comparison
Compare POLYMED with any stock or ETFCompare POLYMED with any stock or ETF
POLYMED
POLYMED Holdings
POLYMED Shareholdings
POLYMED Promoter Holdings Trend
POLYMED Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
POLYMED Institutional Holdings Trend
POLYMED Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
POLYMED Shareholding Pattern
POLYMED Shareholding Pattern
POLYMED Shareholding History
POLYMED Shareholding History
Foreign Institutions
Mutual Funds Invested in POLYMED
Mutual Funds Invested in POLYMED
No mutual funds holding trends are available
Top 5 Mutual Funds holding Poly Medicure Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 5.1940% | Percentage of the fund’s portfolio invested in the stock 2.42% | Change in the portfolio weight of the stock over the last 3 months 0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/118 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.6469% | Percentage of the fund’s portfolio invested in the stock 0.89% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/62 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7629% | Percentage of the fund’s portfolio invested in the stock 2.55% | Change in the portfolio weight of the stock over the last 3 months -0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 18/38 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing POLYMED stock
smallcases containing POLYMED stock
Looks like this stock is not in any smallcase yet.
POLYMED Events
POLYMED Events
POLYMED Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
POLYMED has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.28%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.78 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
POLYMED Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
POLYMED has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.28%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.78 every year
POLYMED Upcoming Dividends
POLYMED Upcoming Dividends
No upcoming dividends are available
POLYMED Past Dividends
POLYMED Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹3.50
Dividend/Share
₹3.50
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateSep 19, 2024
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateSep 21, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 21, 2023
Cash Dividend
Ex DateEx DateSep 16, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 16, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 16, 2021
POLYMED Stock News & Opinions
POLYMED Stock News & Opinions
Articles & Videos
Earnings
Poly Medicure consolidated net profit declines 16.78% in the December 2025 quarter
Net profit of Poly Medicure declined 16.78% to Rs 70.93 crore in the quarter ended December 2025 as against Rs 85.23 crore during the previous quarter ended December 2024. Sales rose 16.37% to Rs 493.66 crore in the quarter ended December 2025 as against Rs 424.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales493.66424.21 16 OPM %22.5226.97 - PBDT133.17134.59 -1 PBT104.41113.23 -8 NP70.9385.23 -17 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Poly Medicure to convene board meeting
Poly Medicure will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Spotlight
Volumes jump at Poly Medicure Ltd counter
Dr Agarwals Health Care Ltd, Nava Ltd, Trent Ltd, Redington Ltd are among the other stocks to see a surge in volumes on NSE today, 06 January 2026.Poly Medicure Ltd saw volume of 14.7 lakh shares by 14:14 IST on NSE, a 11.86 fold spurt over two-week average daily volume of 1.24 lakh shares. The stock increased 3.14% to Rs.1,778.40. Volumes stood at 96746 shares in the last session.Dr Agarwals Health Care Ltd notched up volume of 8.65 lakh shares by 14:14 IST on NSE, a 10.13 fold spurt over two-week average daily volume of 85357 shares. The stock rose 2.53% to Rs.512.75. Volumes stood at 59639 shares in the last session.Nava Ltd saw volume of 22.69 lakh shares by 14:14 IST on NSE, a 8.66 fold spurt over two-week average daily volume of 2.62 lakh shares. The stock increased 5.67% to Rs.616.30. Volumes stood at 4.22 lakh shares in the last session.Trent Ltd witnessed volume of 43.96 lakh shares by 14:14 IST on NSE, a 6.65 times surge over two-week average daily volume of 6.61 lakh shares. The stock dropped 8.40% to Rs.4,057.70. Volumes stood at 5.1 lakh shares in the last session.Redington Ltd witnessed volume of 84.04 lakh shares by 14:14 IST on NSE, a 5.11 times surge over two-week average daily volume of 16.46 lakh shares. The stock increased 3.25% to Rs.287.50. Volumes stood at 13.72 lakh shares in the last session.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Volumes soar at Poly Medicure Ltd counter
Syrma SGS Technology Ltd, Transformers & Rectifiers India Ltd, HEG Ltd, K E C International Ltd are among the other stocks to see a surge in volumes on NSE today, 11 November 2025.Poly Medicure Ltd clocked volume of 23.67 lakh shares by 14:14 IST on NSE, a 22.16 times surge over two-week average daily volume of 1.07 lakh shares. The stock gained 11.15% to Rs.2,070.00. Volumes stood at 1.18 lakh shares in the last session.Syrma SGS Technology Ltd clocked volume of 178.41 lakh shares by 14:14 IST on NSE, a 14.45 times surge over two-week average daily volume of 12.35 lakh shares. The stock gained 3.34% to Rs.835.00. Volumes stood at 12.05 lakh shares in the last session.Transformers & Rectifiers India Ltd saw volume of 235.21 lakh shares by 14:14 IST on NSE, a 13.5 fold spurt over two-week average daily volume of 17.42 lakh shares. The stock dropped 9.63% to Rs.283.35. Volumes stood at 32.29 lakh shares in the last session.HEG Ltd witnessed volume of 227.08 lakh shares by 14:14 IST on NSE, a 9.84 times surge over two-week average daily volume of 23.07 lakh shares. The stock increased 3.89% to Rs.539.50. Volumes stood at 15.31 lakh shares in the last session.K E C International Ltd registered volume of 53.21 lakh shares by 14:14 IST on NSE, a 9.64 fold spurt over two-week average daily volume of 5.52 lakh shares. The stock rose 5.32% to Rs.760.65. Volumes stood at 12.77 lakh shares in the last session.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Poly Medicure consolidated net profit rises 5.02% in the September 2025 quarter
Net profit of Poly Medicure rose 5.02% to Rs 91.84 crore in the quarter ended September 2025 as against Rs 87.45 crore during the previous quarter ended September 2024. Sales rose 5.68% to Rs 443.88 crore in the quarter ended September 2025 as against Rs 420.02 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales443.88420.02 6 OPM %25.8427.42 - PBDT146.62138.70 6 PBT121.69117.98 3 NP91.8487.45 5 Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Poly Medicure standalone net profit rises 2.10% in the September 2025 quarter
Net profit of Poly Medicure rose 2.10% to Rs 89.05 crore in the quarter ended September 2025 as against Rs 87.22 crore during the previous quarter ended September 2024. Sales rose 3.50% to Rs 416.54 crore in the quarter ended September 2025 as against Rs 402.47 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales416.54402.47 3 OPM %26.7028.02 - PBDT142.16136.90 4 PBT118.01116.93 1 NP89.0587.22 2 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Poly Medicure announces board meeting date
Poly Medicure will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Poly Medicure to conduct AGM
Poly Medicure announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Poly Medicure consolidated net profit rises 25.72% in the June 2025 quarter
Net profit of Poly Medicure rose 25.72% to Rs 93.08 crore in the quarter ended June 2025 as against Rs 74.04 crore during the previous quarter ended June 2024. Sales rose 4.79% to Rs 403.21 crore in the quarter ended June 2025 as against Rs 384.78 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales403.21384.78 5 OPM %26.3227.01 - PBDT146.20118.11 24 PBT122.9598.46 25 NP93.0874.04 26 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Poly Medicure appoints Executive Director
The Board of Poly Medicure at its meeting held on 08 August 2025 has approved appointment of Pankaj Kumar Gupta (DIN: '11232604) as an Executive Director of the Company for a period of Five (5) consecutive years commencing from 08 August 2025. Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.04%, vs industry avg of 24.67%
Over the last 5 years, market share decreased from 33.85% to 23.63%
Over the last 5 years, net income has grown at a yearly rate of 28.71%, vs industry avg of 28.7%